These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27845911)

  • 1. Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?
    Thillai K; Lam H; Sarker D; Wells CM
    Oncotarget; 2017 Feb; 8(8):14173-14191. PubMed ID: 27845911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration.
    King H; Thillai K; Whale A; Arumugam P; Eldaly H; Kocher HM; Wells CM
    Sci Rep; 2017 Feb; 7():42575. PubMed ID: 28205613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
    Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
    Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
    Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
    J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of p21-activated kinases in pancreatic cancer.
    Yeo D; He H; Baldwin GS; Nikfarjam M
    Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.
    Conway JR; Herrmann D; Evans TJ; Morton JP; Timpson P
    Gut; 2019 Apr; 68(4):742-758. PubMed ID: 30396902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
    Reichert M; Saur D; Hamacher R; Schmid RM; Schneider G
    Cancer Res; 2007 May; 67(9):4149-56. PubMed ID: 17483325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma.
    Ma Y; Nikfarjam M; He H
    Cancer Lett; 2022 Nov; 548():215868. PubMed ID: 36027997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation.
    Wang K; Baldwin GS; Nikfarjam M; He H
    World J Gastroenterol; 2018 Sep; 24(33):3709-3723. PubMed ID: 30197477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer.
    Ebrahimi S; Hosseini M; Shahidsales S; Maftouh M; Ferns GA; Ghayour-Mobarhan M; Hassanian SM; Avan A
    Curr Med Chem; 2017; 24(13):1321-1331. PubMed ID: 28176634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic pathways in pancreatic ductal adenocarcinoma.
    Hamacher R; Schmid RM; Saur D; Schneider G
    Mol Cancer; 2008 Jul; 7():64. PubMed ID: 18652674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
    García-Reyes B; Kretz AL; Ruff JP; von Karstedt S; Hillenbrand A; Knippschild U; Henne-Bruns D; Lemke J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.
    Baril P; Gangeswaran R; Mahon PC; Caulee K; Kocher HM; Harada T; Zhu M; Kalthoff H; Crnogorac-Jurcevic T; Lemoine NR
    Oncogene; 2007 Mar; 26(14):2082-94. PubMed ID: 17043657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?
    Baer R; Cintas C; Therville N; Guillermet-Guibert J
    Adv Biol Regul; 2015 Sep; 59():19-35. PubMed ID: 26166735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
    Wang L; Zhang B; Zheng W; Kang M; Chen Q; Qin W; Li C; Zhang Y; Shao Y; Wu Y
    Sci Rep; 2017 Jul; 7(1):5384. PubMed ID: 28710412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.